Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid Arthritis

PHASE3TerminatedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 24, 2000

Primary Completion Date

June 20, 2002

Study Completion Date

June 24, 2002

Conditions
Juvenile Rheumatoid Arthritis
Interventions
DRUG

Etanercept

Administered by subcutaneous injection twice a week

DRUG

Placebo to Etanerceot

Administered by subcutaneous injection twice a week

DRUG

Methotrexate

Administered orally or subcutaneously once a week at the same dose as prior to study entry

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY

NCT03781375 - Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter